IRCT20230202057310N15 IRCT 2024-12-27 Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan. Rosuvastatin and 10-week resistance band exercises for obese individuals of Multan Comparative effects of rosuvastatin and 10-week resistance band exercises for obese individuals of Multan 2025-01-06 anticipated 380 Complete https://irct.ir/trial/80827 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization will be done by computer-generated numbers to ensure fairness. Medications will be given in numbered white boxes, each with a unique medication number. The treatment codes will be kept by the principal investigator, Blinding description: Statistical analyser and outcome assessor will be kept blind so that the result obtained will be without biasness. 1-2 Obesity. Intervention 1: Intervention group: Group 1: Participants in the drug intervention group will receive e.g., Rosuvastatin 5mg administered orally once daily. This medication has been selected based on its established efficacy in lowering LDL cholesterol and improving overall lipid profiles. Intervention 2: Intervention group: Participants in the exercise intervention group will undergo a structured resistance training program, tailored to individual fitness levels and conducted under the supervision of a certified exercise trainer.Exercise Protocol: The exercise regimen will include a 5-minute warm-up, 30 minutes of resistance training (including chest press, seated row, shoulder press, biceps curl, squats, deadlift, wood chopper, Russian twists), followed by a 5-minute cool-down. Training sessions will be held three times a week for 10 weeks. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is N/A